Presentation is loading. Please wait.

Presentation is loading. Please wait.

Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia.

Similar presentations


Presentation on theme: "Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia."— Presentation transcript:

1 Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes  Gilbert R. Thompson, Mary Seed, Rossi P. Naoumova, Clare Neuwirth, Shahenaz Walji, Timothy J. Aitman, James Scott, Nicolas B. Myant, Anne K. Soutar  Atherosclerosis  Volume 243, Issue 1, Pages (November 2015) DOI: /j.atherosclerosis Copyright © 2015 Elsevier Ireland Ltd Terms and Conditions

2 Fig. 1 Comparison of pre- and on-treatment serum total cholesterol (TC) in dead and alive FH homozygotes. The on-treatment TC in patients who were on apheresis was calculated as the mean of the pre-procedure values. Atherosclerosis  , DOI: ( /j.atherosclerosis ) Copyright © 2015 Elsevier Ireland Ltd Terms and Conditions


Download ppt "Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia."

Similar presentations


Ads by Google